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Mucus protects, moisturizes, and lubricates mucosal sur- cells in the mouse most likely represents metaplastic conver-
faces. A child swirling mucus on his or her tongue has sion of Clara cells into mucous cells, whereas in people,
performed an experiment on its biophysical properties and mucous secretory cell hyperplasia is predominant. Thus,
is likely to be equally aware of the potential for dramatic the valuable lessons from mice must be translated to human
increases in mucus, as with the common cold. However, too cells and, ultimately, human beings.
much of a good thing may be bad, and mucus hypersecretion The article by Vermeer and colleagues (3) in this issue
may contribute to the pathophysiology of asthma, chronic of the AJRCMB is an example of an in vitro study using
bronchitis, and cystic fibrosis, as well as sinusitis and otitis human tracheobronchial epithelial cells cultured at air–liquid
media. Copious, hyperviscous mucus may directly obstruct interface conditions that promote mucous and ciliated cell
airflow or impair mucociliary clearance. Stagnant mucus differentiation resembling that found in vivo (Figure 1). The
likely serves as both a nidus for bacterial colonization and authors make the important point that interleukin (IL)-9
perpetuates chronic infection. stimulation of mucous secretory cell hyperplasia is context-
Mucus hypersecretion is driven by mucous secretory cell dependent. When IL-9 was added to mature, well differenti-
hyperplasia and metaplasia, defined as more mucous secre- ated cultures there was apparently little effect, but if IL-9
tory cells in proximal airways where they are usually found, was added to actively differentiating or wounded cultures
and appearance in distal airways where they are normally there was an increase in the number of mucous secretory
absent, respectively. These phenotypic changes in the air- cells and in secreted mucous. The authors speculate that
way epithelium are hallmarks of chronic airway disease. the combination of elevated IL-9 and pathologic epithelial
Because increased mucus production is a common clinical turnover may underlie the mucus hypersecretory phenotype
complaint against which there are no specific therapies, and in asthma. In contrast, IL-13 alone, without injury, increased
because improving mucociliary clearance may be beneficial, mucous secretory cells. A handful of other studies using
this is an area of great current interest. similar human cultures have examined the stimulation of
Our understanding of the complex programs governing mucous secretory cells (Table 2). These studies highlight
mucous secretory cell differentiation, enhanced secretory the technical and experimental challenges associated with
cell proliferation rates, increased expression of mucin genes, quantifying mucus and mucous cells in this most relevant
and hyperproduction and hypersecretion of mucin glyco- of models. The main purpose of this short perspective is
proteins is incomplete, but current research is elucidating to discuss key elements of analyzing the mucus secretory
specific stimuli altering mucous secretory cells. As reviewed apparatus in well differentiated human cell cultures. Similar
in Table 1, genetically manipulated mice provide new in- principles will hold in attempts to measure mucins in human
sights regarding mucous secretory cell biology. It is impor- lavage fluid, expectorated sputum, and biopsies.
tant to recognize that mice normally have few mucous secre-
tory cells in their trachea, bronchi, and bronchioles that Human Airway Epithelial Cell Culture Sample Size
are instead dominated by a Clara cell lineage system (1). Since the breakthrough study of Whitcutt, Adler, and Wu
Conversely, in human beings, mucous secretory cells are (4), the gold standard for obtaining well-differentiated air-
found in the surface epithelium of many airway generations, way epithelial cultures is to grow cells on a porous support
down to the smallest 1 mm diameter bronchioles where at an air–liquid interface. This method is readily applicable
there is a transition to a limited area of Clara cell–rich to human cells as indicated by studies too numerous to
terminal bronchioles (2). Therefore, more mucous secretory mention in this brief Perspective. Yet, these cultures are
much more challenging than conventional cells on plastic.
Limited numbers of labs procure their own human airway
(Received in original form January 15, 2003) cells. Commercially available human airway cells are pro-
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Figure 1. Paraffin sec-TABLE 1
tions of formalin-fixed,A partial list of cytokine/chemokine regulation of mucous
passage 1 human tra-secretory cells in genetically manipulated mice
cheobronchial epithe-
Factor Effect References lial cells grown in cul-
ture at an air–liquid
IL-4 Transgenic mice expressing IL-4 in the lung (14–16) interface for 21 d. The
show lung mucus accumulation and hyper- porous support is visible
secretion, mucus cell metaplasia and in- below the cells. Mucous
creased secretory cell granules
mMuc5ac expression as well as cell surface
IL-5 Transgenic mice expressing IL-5 in the lung (17) materials are easily vis-
show mucus accumulation and mucus cell ualized in the lower
metaplasia in the airways panel. H&E, hema-
IL-9 Transgenic mice expressing IL-9 in the lung (18–20) toxylin and eosin stain;
show airway mucus accumulation and AB-PAS, alcian blue–
increased mMuc2 and mMuc5ac expression periodic acid-Schiffs
IL-10 Transgenic mice overexpressing IL-10 show (21) stain. Original magni-
mucus cell metaplasia fication, 400.
IL-10-deficient mice show reduced mucus (22)
production in response to lung insult
IL-11 Transgenic mice overexpressing IL-11 in the (23)
lung show mucus hypersecretion and mucus
northern blots, nuclease protection assay, and quantitativecell metaplasia
reverse transcriptase–polymerase chain reaction (RT-PCR)IL-13 Transgenic mice overexpressing IL-13 in the (24, 25)
are particularly useful tools for analyzing cultures. Recentlung show mucus hypersecretion and mucus
cell metaplasia advances in the sequencing of mucin genes facilitates this
IL-13-deficient mice show reduced mucus (26) task and also enables analysis of MUC1 and MUC4, as well
hypersecretion after acute lung insult as any newly discovered or less well-studied mucins. As
discussed below, measuring mucin mRNA is more straight-Definition of abbreviation: IL, interleukin.
forward than analyzing mucin glycoproteins. However,
measurement of mucin mRNA was not exploited by Ver-
meer and colleagues (3). It is notable that Northern blot
and nuclease protection require more RNA than does RT-different lots of cells will cause variability and dictate larger
PCR. Quantitative RT-PCR, using optimized and specificsample sizes. This raises the important issue of definition
primers, will likely find great use in the future. Promoterof sample number. Do 20 replicate cultures from one indi-
sequences of MUC5AC and MUC5B have been definedvidual represent an n of 20? Careful studies of mucus hyper-
(5, 6), and promoter activity can be readily assayed in cellsecretion will require consistently differentiated cultures
lines by expressing a reporter gene under the control offrom a representative population of humans. As a minimum,
mucin promoters (7). However, due to the low transfectabil-we suggest that the old laboratory axiom of “three times
ity of well-differentiated airway epithelial cells with routinein triplicate” is applicable, where three times represents a
plasmid protocols, this strategy is not yet feasible. Adenovi-minimum of cultures from three different individuals, and
ral vectors combined with methods to enhance access to theeach experimental group consists of three replicate cultures.
basolateral membrane (8) offer promise for future promoter–In practice, many parameters will require much larger sam-
reporter studies. For MUC2, MUC5AC, and MUC5B, thisple sizes. It is important for authors to clearly present their
will rely on adequate transfection of mucous secretory cells.working definitions of sample size.
Quantitating Mucin GlycoproteinsDefining and Measuring Mucus
Ultimately, it will be important to quantitate productionRespiratory tract mucus consists of biomolecules, ions, and
and secretion of mucin glycoproteins. The approach of met-water, including the highly glycosylated, polymeric, se-
abolic labeling with 3H glucosamine followed by apicalcreted, gel-forming mucins MUC5AC, MUC5B, and, on
harvest of secretions, enzyme digestion, gel filtration, andoccasion, MUC2. Also present are highly glycosylated, mo-
density gradient purification (9, 10) is a time-tested butnomeric MUC1 and MUC4 mucins shed from the cell surface
unwieldy standard. This has led to a search for more conve-as well as additional N and/or O-glycosylated proteins, lip-
nient assays. However, this is difficult for several reasons.ids, and glycolipids. The complex and variable nature of
First, mucus varies from a viscous fluid to a strongly visco-mucins and their carbohydrate modifications present chal-
elastic gel, not dispersable in physiological solutions. Dis-lenges for their quantitation.
persion is achieved using chaotropes such as 4–6 M guanidi-
Mucin Gene Expression nium chloride combined with reducing agents such as
dithiothreitol. While effective for dispersion, such treatmentThe gel-forming mucins predominantly determine mucus
inhibits the use of the sample in simple biochemical assays.viscoelastic and adhesive properties. Thus, standard quan-
Within the resultant mixture of large and small molecules,titative methods for assessing MUC2, MUC5AC, and
MUC5B messenger RNA (mRNA) abundance, such as smaller, more dynamically active species will blot on mem-
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clonal antibody. As for the biochemical measurements dis-TABLE 2
cussed above, it is important to recognize that terminalPartial list of cytokine/chemokine regulation of mucous
sugar residues may vary based on human polymorphismssecretory cells in well-differentiated human airway
epithelial cell cultures. and the metabolic state of the cell. Thus, lectins should be
viewed as risky surrogate markers. Additionally, rigorous
Factor Effect References
morphometry is predicated on solid methodologic princi-
IL-4 Decreases MUC5AC expression and MUC5AC ples, including adequate, unbiased sampling, clear structural
secretion in normal HNE cells (27) definitions, and special considerations for enumeration of
Increases MUC8 expression in normal HNE cells variably sized objects or oriented samples as previously
Decreases MUC5AC and MUC5B expression in outlined for studies of the lung (13). Similar to the sample
HBE cells (28) size definitions noted above, it is important for authors to
IL-9 Increases MUC2 and MUC5AC expression in
clearly present the details of the morphometric analysis.normal HBE cells (19, 29)
IL-13 Increases the number of mucous cells in normal Conclusion
HNE cells (30)
The pulmonary community is entering an era in which weDecreases MUC5AC expression in normal HNE
cells (31) may satisfy our child-like fascination with mucus. We will
Increases MUC2 and MUC8 expression likely uncover key aspects regulating the quantity, quality,
and secretion of mucus, expanding our knowledge of itsDefinition of abbreviations: HBE, human bronchial epithelial; HNE, human
role in normal physiology and in disease. Additional studiesnasal epithelial; IL, interleukin.
such as those of Vermeer and colleagues (3), using well-
differentiated primary human airway epithelial cells and
incorporating future improvements in our analytic capacity
of the mucus secretory apparatus, will hopefully suggestbranes or bind to ELISA plates more efficiently, resulting
novel therapies beneficial to our fight against airway disease.in under-representation of mucin. One solution is a capture
assay, such as a sandwich ELISA. However, if the sample
required dispersion, chaotropes or reducing agents must References
be removed or decreased to avoid denaturing the capture
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